Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
2.985
-0.035 (-1.16%)
Feb 13, 2026, 11:36 AM EST - Market open

MRVI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
7637738661,8825,5082,748
Market Cap Growth
6.98%-10.72%-54.00%-65.83%100.45%-
Enterprise Value
8971,0761,2742,1815,7103,117
Last Close Price
3.025.456.5514.3141.9028.05
PE Ratio
---8.5530.2635.74
Forward PE
---23.4242.8279.20
PS Ratio
2.252.983.002.136.899.67
PB Ratio
1.781.341.102.0810.1017.76
P/TBV Ratio
---41.94121.96-
P/FCF Ratio
--14.273.6315.5721.68
P/OCF Ratio
-103.566.863.5114.9518.06
PEG Ratio
-----2.87
EV/Sales Ratio
4.664.154.412.477.1410.97
EV/EBITDA Ratio
--80.193.6210.0524.05
EV/EBIT Ratio
---3.8310.5130.03
EV/FCF Ratio
--21.004.2016.1424.58
Debt / Equity Ratio
0.850.650.770.651.063.82
Debt / EBITDA Ratio
--18.950.950.994.56
Debt / FCF Ratio
--10.071.131.634.67
Asset Turnover
0.180.210.150.420.500.31
Inventory Turnover
3.172.973.153.573.313.35
Quick Ratio
4.326.377.217.077.132.20
Current Ratio
5.297.538.007.707.892.54
Return on Equity (ROE)
-40.92%-37.98%-16.33%67.65%134.05%52.65%
Return on Assets (ROA)
-7.78%-3.64%-0.81%16.96%21.30%7.02%
Return on Invested Capital (ROIC)
-23.53%-9.98%0.65%71.03%89.01%19.63%
Return on Capital Employed (ROCE)
-16.80%-7.60%-1.70%26.20%29.80%9.10%
Earnings Yield
-15.67%-18.74%-13.75%11.70%3.31%3.24%
FCF Yield
-8.59%-2.87%7.01%27.57%6.42%4.61%
Buyback Yield / Dilution
-5.96%-4.54%48.33%0.96%-791.80%88.61%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q